Mr. David J. Albright, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 409 N 4th St, Sunbury, PA 17801 Phone: 570-286-1482 Fax: 570-286-5243 |
Kyle Lee Mcmanigle, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1072 Market St, Sunbury, PA 17801 Phone: 570-286-8521 Fax: 570-286-6197 |
Stacey Renee Lauffer, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 385 State St, Sunbury, PA 17801 Phone: 570-286-6773 Fax: 570-286-7967 |
Kevin Kaczmarek, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 130 N 4th St, Sunbury, PA 17801 Phone: 570-286-1482 Fax: 570-286-5243 |
Kelsey L Williard, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1072 Market St, Sunbury, PA 17801 Phone: 570-286-8521 Fax: 570-286-6197 |
Nicole Rebecca Krebs, PAA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 409 N 4th St, Sunbury, PA 17801 Phone: 570-286-1482 Fax: 570-286-5243 |
News Archive
MDxHealth SA, a leading molecular diagnostics company in the field of personalized medicine, announced today that it will extend its agreement with Merck KGaA, Darmstadt, Germany, for use of MDxHealth's MGMT assay in Merck KGaA's brain cancer clinical trials.
Virginia Commonwealth University has received a five-year, $6 million grant for clinical research and education directed toward the identification, evaluation and development of safe and effective treatments for cocaine addiction.
Stem-cell based therapies to strengthen the heart muscle and treat other diseases are beginning to show promise in human clinical trials.
American International Biotechnology Services (AIBioTech), a division of Bostwick Laboratories, Richmond, VA, today announced that it is one of four contractors awarded a new government contract valued at approximately $21 million. AIBioTech provides integrated research and development sciences and clinical testing services to physicians and life sciences investigators in biotechnology and pharmaceutical companies, academic institutions, and government agencies. The new contract will be funded in phases, with the first AIBioTech phase valued at nearly $3 million. AIBioTech has assembled a consortium of seven leading technology and biotechnology companies who are poised to meet all of the anticipated scientific objectives.
› Verified 6 days ago